 |
|
Medicinal Range |
|
|
Animal Health |
|
|
Personal Care |
|
|
|
|
|
|
|
|
To view the clinical papers, your system needs the free Adobe Acrobat Reader, version 4 or later.
Click here to download. |
|
|
 |
|
| Total no. of papers:277 -
Clinical Papers:185, Experimental
Papers:92 |
| (Research papers
based on Indications) |
| Highlighted journal
names are international publications |
| |
| In the prevention
and treatment of viral hepatitis |
|
- Liver disorders during pregnancy and their management
Arun Kumar Mitra, MBBS, DGO, MO, FICOG, FRCOG PhD (London)
Former Professor and Head, Department of Obstetrics and Gynecology, Medical College. Calcutta.
Pralhad S. Patki*, M.D., Head - Medical Services and Clinical Trials S.K. Mitra, M.D., Executive Director
R&D Center, The Himalaya Drug Company, Bangalore, India. The Antiseptic 2008; 105 (4): 193-196
- Meta-analysis
of 50 Phase III clinical trials in evaluation of efficacy and safety of Liv.52 in infective
hepatitis
Kolhapure, S.A., M.D., Senior Medical Advisor, and
Mitra, S.K., M.D., Executive Director,Research and Technical Service, R&D Center,
The Himalaya Drug Company, Bangalore, India, Medicine Update (2004): 12(2), 51-61.
- Comparative
efficacy of five indigenous compound formulations in patients
of acute viral hepatitis
Dange, S.V., Lecturer, Patki, P.S., Reader,
Pawar, S.S., Laboratory Technician, Phadke, S.A., Associate Professor
and Shrotri, D.S., Professor and Head, Departments of Pharmacology
and Microbiology, B.J. Medical College, Pune, India, Maharashtra
Medical Journal (1989): (XXXVI), 5, 75.
- A
trial with Liv.52 in infective hepatitis
Vijaykumar, S. Karchi, X-ray Unit, Talkoti,
Karnataka, Capsule (1988): Feb./Mar.,126.
- A
study of serum glycolytic enzymes and serum B hepatitis in relation
to Liv.52 therapy
Patney, N.L. and Sumanbala Pachori, Postgraduate
Department of Medicine, S.N. Medical College, Agra, Uttar Pradesh,
The Medicine and Surgery (1986): (XXVI), 4, 9.
- Liv.52
in infective hepatitis including precoma and coma
Phadke, M.A. (Mrs.), Alka Datar and Nainesh
M. Vora, B.J. Medical College and Sassoon General Hospitals, Pune,
Maharashtra, Capsule (1984): (22), 8, 170.
- Studies
with Liv.52 in the treatment of infective hepatitis, chronic active
hepatitis and cirrhosis of the liver
Mandal, J.N. and Roy, B.K., Department
of Medicine, Medical College and Hospital, Calcutta, West Bengal,
Probe (1983): (XXII), 4, 217.
- Management
of infective hepatitis
Sreenivasa Rao, Y., I.S.&W.P. Hospital,
Jamshedpur, Bihar, Probe (1983): (XXII), 2, 107.
- Role
of Liv.52 in the treatment of infective hepatitis
Chowdhury, A.B., Government Subdivisional
Hospital, Karimganj, Cachar District, Assam, Capsule (1981): 3,
50.
- Infective
hepatitis and Liv.52 drops
Dinesh Chandra Misra, Primary Health Centre,
Marteengaj, Azamgarh, Uttar Pradesh, Capsule (1981): 6, 122.
- Liv.52
therapy in acute infective hepatitis
Kesarkar, A.S., S.V. Road, Goregaon West,
Bombay, Maharashtra, Capsule (1981): 4, 74.
- Role
of Liv.52 in the treatment of infective hepatitis
Paritosh Biswas, Ashoke Nagar, (24 Parganas),
Alipur, West Bengal, Capsule (1980): 4, 74.
- Study
of Liv.52 therapy in infective hepatitis in children
Shakuntala Saxena, (Mrs.), Ashok Kumar
Garg and Ashok Jain, Department of Paediatrics, S.M.S. Medical
College and Hospital, Jaipur, Rajasthan, Current Medical Practice
(1980): (24), 5, 194.
- Viral
hepatitis and Liv.52
Uday Shankar Mandal, Giridih Block, Sirsia,
Giridih, Bihar, Capsule (1980): 3, 50.
- Liv.52
in acute viral hepatitis – Results of a double-blind study
Habibullah, C.M., Vinod Chandra, Padmanaban,
C.G. and Ramakrishna, R., Department of Gastroenterology, Osmania
General Hospital, Hyderabad, Andhra Pradesh, The Antiseptic (1978):
(75), 8, 491.
- Effect
of an indigenous preparation Liv.52 on hepatitis B antigen-carriage
Kelkar, S.S., Grant Medical College, Bombay,
Maharashtra, and Mahajan, R.K., Medical College, Aurangabad, Maharashtra,
Probe (1978): (XVII), 2, 150.
- A
preliminary report on the role of Liv.52, an indigenous drug in
serum B hepatitis (Australia antigen positive) cases
Patney, N.L. and Ashok Kumar, Postgraduate
Department of Medicine, S.N. Medical College, Agra, Uttar Pradesh,
Probe (1978): (XVII), 2, 132.
- Clinical
management of severe acute hepatic failure with special reference
to Liv.52 therapy
Sethi, J.P. and Madhulika Sharma, Department
of Medicine, S.M.S. Medical College and Hospital, Jaipur, Rajasthan,
Probe (1978): (XVII), 2, 155.
- Liv.52
therapy in viral hepatitis (A clinico-biochemical study)
Banerjee, L.K., Sahu, N.N., Ray, S.S.
and Daljit Singh, BSF Base Hospital, Kadamtala, Siliguri, Darjeeling,
West Bengal, Capsule (1977): 8, 170.
- A
clinical study of infective hepatitis treated with Liv.52
Ila V. Desai, Dudhia, M.V. and Gandhi,
V.K., Sheth K.M. School of Postgraduate Medicine and Research,
and Sheth V.S. General Hospital and Smt. N.H.L. Municipal Medical
College, Ahmedabad, Gujarat, Indian Paediatrics (1977): 3, 197.
- Observations
on the treatment of infective hepatitis with an indigenous drug
Liv.52
Singh, K.K., Department of Medicine, Singh,
Y.K., Sinha, S.K., Department of Paediatrics, Sharma, V., Department
of Medicine and Mishra, B.N., Department of Medicine, Darbhanga
Medical College, Laheriasarai, Bihar, Indian Medical Journal (1977):
5, 69.
- Clinical
trial of Liv.52 drops in infective hepatitis – A comparative
study with broad spectrum antibiotics and corticosteroids
Agrawal, V.K. and Meena Sareen, M.L.N.
Medical College, Allahabad, Uttar Pradesh, Probe (1976): (XV),
2, 112.
- Viral
hepatitis in children
Chawhan, R.N., Talib, S.H., Talib, V.H.,
Sengupta, S.R. and Patil, S.D., Medical College, Aurangabad, Uttar
Pradesh, The Medicine and Surgery (1976): 3, 9.
- Efficacy
of an indigenous compound preparation Liv.52 in acute viral hepatitis
– A double-blind study
Sama, S.K., Krishnamurthy, L., Ramachandran,
K. and Krishnan Lal, All India Institute of Medical Sciences,
Ansari Nagar, New Delhi, Indian Journal of Medical Research (1976):
5, 738.
- A
study of chronic hepatitis in northern India
Singh, D.S., Jawaharlal Institute of Postgraduate
Medical Education and Research, Pondicherry, Sama, S.K., Sir Ganga
Ram Hospital, New Delhi and Singh, G., Department of Gastroenterology,
All India Institute of Medical Sciences, New Delhi, Indian Journal
of Medical Research (1976): (64), 12,1728.
- Viral
hepatitis in children
Reddi, Y.R., Sudhakar Rao, V., Rohini,
K. and Kusuma, G., Institute of Child Health, Niloufer Hospital,
Hyderabad, Andhra Pradesh, Indian Paediatrics (1975): (XII), 8,
659.
- Studies
on Liv.52 in hepatic disorders – Part II
Sharma, N.L., Lahori, U.C. and Mehta,
S.K., King George Medical College, Lucknow, Uttar Pradesh, Probe
(1975): (XIV), 2, 126.
- Liv.52
in infective hepatitis
Bhandari, N.R. and Shashi Gupta (Miss.),
Department of Paediatrics, Gandhi Medical College, Bhopal, Madhya
Pradesh, Probe (1974): (XIV), 1, 68.
- Acute
infectious hepatitis with fulminant hepatic failure – A study
of 289 cases
Deshpande, R.S., Kasturba Hospital for
Infectious Diseases, Sane Guruji Marg, Bombay, Maharashtra, Probe
(1974): (XIV), 1, 1.
- Trial
of Liv.52 in infectious hepatitis in children in Goa
Harish Mazumdar and Mira Mazumdar, Department
of Paediatrics, Goa Medical College, Panaji, Goa, Probe (1974):
(XIV), 1, 28.
- Studies
with Liv.52 in infective hepatitis
Jain, K.C., Khanijo, S.K. and Bisarya,
B.N., Department of Medicine, S.S. Medical College, Rewa, Madhya
Pradesh, Probe (1974): (XIV), 1, 64.
- Liv.52
therapy in infective hepatitis
Khetarpal, S.K. and Veera Kumar, E., Department
of Paediatrics, Medical College, Amritsar, Punjab, Probe (1974):
(XIV), 1, 59.
- Trial
of Liv.52 in infectious hepatitis in children in Goa
Mazumdar, H. and Mazumdar, M., Department
of Paediatrics, Goa Medical College, Panaji, Goa, Probe (1974):
(XIV), 1, 82.
- Liv.52
in viral hepatitis with special reference to its use in precoma
and coma
Mitra, D.K., Ashrafuddin, S. and Talib,
S.H., Department of Medicine, Medical College, Aurangabad, Maharashtra,
Probe (1974): (XIV), 1, 14.
- Role
of Liv.52 and steroids in the management of viral hepatitis in
children
Reddi, Y.R., Rohini, K., Kusuma, G. and
Sudhakar Rao, V., Osmania Medical College, Institute of Child
Health and Niloufer Hospital, Hyderabad, Andhra Pradesh, Probe
(1974): (XIV), 1, 35.
- Studies
on Liv.52 in hepatic disorders – Part I
Sharma, N.L., Lahori, U.C. and Mehta,
S.K., King George Medical College, Lucknow, Uttar Pradesh, Probe
(1974): (XIV), 1, 54.
- Observations
on the therapy of acute infectious hepatitis with Liv.52
Shishupal Ram and Kumar, P., Liver Research
Unit, Hospital for Children, Patna Medical College Hospital, Patna,
Bihar, Probe (1974): (XIV), 1, 66.
- Studies
on 222 cases of acute infective hepatitis during an epidemic
Sinha, B.B., Kurzi Holy Family Hospital,
Patna, Bihar, Probe (1974): (XIII), 3, 130.
- Liv.52
trial in infective hepatitis
Mehrotra, M.P.,and Dineshchandra Mathur,
Research Fellow, S.N. Medical College, Agra, Uttar Pradesh, The
Antiseptic (1973): (70), 2, 114.
- Liv.52
in the treatment of acute infective hepatitis
Sarkar, M.K., Burn and Co., Durgapur,
Burdwan, Rajasthan, The Indian Practitioner (1973): 8, 395.
- Clinico-biochemical
study of infective hepatitis with special reference to Liv.52
therapy
Dave, D.S., Rajput, V.J. and Gupta, M.R.,
Department of Paediatrics, G.R. Medical College, Gwalior, Madhya
Pradesh, Probe (1972): (XI), 4, 214.
- Therapeutic
effects of Liv.52 in post-necrotic hepatitis
Gupta, S., Khatri, R.L. and Srivastava,
G., Maulana Azad Medical College, New Delhi, Probe (1972): (XII),
1, 15.
- Therapy
of infectious hepatitis and other liver disorders
Gupta, S., Khatri, R.L. and Srivastava,
G., Maulana Azad Medical College, New Delhi, Probe (1972): (XI),
2, 93.
- Liv.52
therapy in viral hepatitis
Patel, G.T., Mruthyunjayanna, B.P., Seetharam,
T.D. and Channe Gowda, A.C., Medicine Unit, Victoria Hospital
and Bangalore Medical College, Bangalore, Karnataka, Probe (1972):
(XI), 2, 112.
- Chronic
active hepatitis (A preliminary observation of 10 cases)
Dasgupta, M. and Mukerjee, A.B., Department
of Medicine, R.K. Mission Seva Pratisthan, Calcutta, West Bengal,
Journal of Indian Medical Profession (1971): 18, 8097.
- Infectious
hepatitis – Study of 100 cases
Deshpande, R.S., Kasturba City Fever Hospital,
Bombay, Maharashtra, Shantilal C. Sheth, Kasturba City Fever Hospital
and Emeritus Director Professor of Paediatrics, Topiwala National
Medical College and Nair Hospital, Bombay, Maharashtra, and Joy
Kutty, M.D., Research Scholar, Bombay, Maharashtra, Current Medical
Practice (1971): 6, 810.
- Some
observations on Liv.52 in the treatment of infective hepatitis
and cirrhosis of liver
Lala Surajnandan Prasad, Department of
Paediatrics, Patna University, and Kaleshwer Prasad, Department
of Paediatrics, Children’s Hospital, Patna Medical College
and Hospital, Patna, Bihar, Probe (1971): (X), 3, 114.
- Liv.52
studies in acute hepatitis
Ramalingam, V., Sundarvalli, N. and Balagopal
Raju, V., Institute of Child Health and Hospital for Children,
Egmore, Madras, Tamil Nadu, Indian Paediatrics (1971): 12, 839.
- Infective
hepatitis – Survey and study of 110 cases
Doddagoudar, M.B., Karnatak Medical College,
Hubli, Karnataka, Probe (1970): (IX), 3, 122.
- Treatment
of viral hepatitis by an indigenous drug – Liv.52
Mukerjee, A.B., Calcutta National Medical
College and Hospitals, and Department of Medicine,Dasgupta, M.,
Ramakrishna Mission Seva Pratishthan, Calcutta, West Bengal, The
Indian Practitioner (1970): June, 357.
- Liv.52
in infective hepatitis
Jaffari, S.M.H. and Shyam Raj, Fever Hospital,
Hyderabad, Andhra Pradesh, The Antiseptic (1969): 5, 353.
- Role
of various types of treatment in infectious hepatitis
Major Arora, J.K., MH Lebong, Darjeeling,
West Bengal, Armed Forces Medical Journal (1969): (XXV), 3, 362.
- Studies
with Liv.52 therapy in infective hepatitis
Sule, C.R., Pai, V.R., Damania, R.F. and
Joshi, V.S. (Miss.), Medicine Unit, Sasoon General Hospitals and
B.J. Medical College, Poona, Maharashtra, Journal of Indian Medical
Profession (1968): 14, 6391.
- Preliminary
observations on the role of Liv.52 in infective-hepatitis with
persistent jaundice
Rath, B.B., Department of Medicine, Sengupta,
S.N., Department of Medicine, and Bose, S.N., Department of Biochemistry,
Bankura Sammilani Medical College and Hospital, Bankura, West
Bengal, Capsule (Undated): (XV), 8, 170.
|
 |
| |
|
| In the prevention
and treatment of alcoholic liver disease |
- Effect
of the hepatoprotective drug Liv.52 on liver damage
M. Kalab, T. Krechler Internal Clinic
of the Medical Faculty of the Charles University in Prague and
The Military Faculty Hospital in Prague, The
Journal of Czech Physicians (1997): (136), 24, 758-760.
- Alcoholic
liver disease – The possibility of ayurvedic therapy
Kulkarni, R.D., Clinical Pharmacology,
Bombay, Maharashtra, The Journal of General Medicine (1992): (4),
2, 11.
- Alcohol
hangover and Liv.52
Chauhan, B.L. and Kulkarni, R.D., R&D
Centre, The Himalaya Drug Co., Bombay, Maharashtra, European
Journal of Clinical Pharmacology (1991): 40, 187.
- Effect
of Liv.52, a herbal preparation, on absorption and metabolism
of ethanol in humans
Chauhan, B.L. and Kulkarni, R.D., R&D
Centre, The Himalaya Drug Co., Bombay, Maharashtra, European
Journal of Clinical Pharmacology (1991): 40, 189.
- Blood,
urine ethanol and acetaldehyde levels from six different alcoholic
beverages and effect of Liv.52
Kulkarni, R.D. and Chauhan, B.L., R&D
Centre, The Himalaya Drug Co., Bombay, Maharashtra, European
Journal of Pharmacology (1990): (183), 5, 1865.
- Addiction
and industry
Alan De Sousa, J.J. Hospital and Grant
Medical College, Bombay, Maharashtra, Industrial Psychiatry Journal
(1989): 2, 1, 5.
- Liv.52
in alcoholism
Alan De Souza, Prakash Gangdev, Ashok
Sinorawala and Manoj Agrawal, Department of Psychiatry, Grant
Medical College and J.J. Hospital, Bombay, Maharashtra, Journal
of Communication Psychiatry (1989): (12), Jan./Mar., 23.
- Injurious
effects of ethyl alcohol on liver function and protective effect
of Liv.52
Doshi, B.S. and Kulkarni, R.D., The Indian
Practitioner (1987): Nov., 965.
- The
mechanism of cellular damage in alcoholic liver disease and the
protective action of Liv.52
Soman, R.N., Bhatia General Hospital,
Tardeo, Bombay, Maharashtra, Probe (1983): (XXII), 3, 164.
- Effect
of ethanol on liver function and its relation to hangover: Protective
effect of Liv.52
Kulkarni, R.D., Grant Medical College,
Bombay, Maharashtra, Indian Drugs (1980): 11, 363.
- Effect
of Liv.52 on different bio-chemical parameters in alcoholic cirrhosis
Dubey, G.P., Aruna Agrawal and Dixit,
S.P., Department of Basic Principles, Institute of Medical Sciences,
Banaras Hindu University, Varanasi, Uttar Pradesh, The Antiseptic
(1977): (91), 6, 205.
- Prolonged
moderate alcohol intake and liver function
Damle, V.B., L.T.M.G. Hospital and L.T.M.
College, Sion, and Kulkarni, R.D., Grant Medical College and J.J.
Group of Hospitals, Bombay, Maharashtra, Probe (1973): (XIII),
1, 31.
|
|
| |
|
| In the prevention
and treatment of pre-cirrhotic conditions and early cirrhosis |
|
- The efficacy of Liv-52 on liver cirrhotic patients: A randomized,
double-blind, placebo-controlled first approach
H. Fallah Huseinia*, S.M. Alavianb, R. Heshmatc, M.R. Heydarid, K. Abolmaalie
a Department of Pharmacology, Institute of Medicinal Plants, No. 97, Bozorgmehr St., Ghods St., Enghelab Ave., Tehran, Iran.
b Baqiatallah University of Medical Sciences, Tehran Hepatitis Center, Tehran, Iran.
c Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran.
d Endocrinology & Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran.
e Baqiatallah University of Medical Sciences, Tehran, Iran Phytomedicine 12(2005) 619-624.
- A
novel mechanism of action prevents ethanol-induced injury – Liv.52 profile of an herbal remedy
Chauhan, B.L. and Kulkarni, R.D., R&D
Centre, The Himalaya Drug Co., Bangalore, Karnataka, Drug
News & Perspectives (1993): (6), 9, 662.
- Liv.52
in the management of various hepatic disorders – A study
of 53 cases
Bharadia, G.R., Kukade, A.L., Kulkarni,
A.S. and Rathod, I.M., Vivekanand Hospital, Latur, Maharastra,
Probe (1986): (XXV), 3, 277.
- Role
of Liv.52 in Indian childhood cirrhosis, with special reference
to its effect on alpha-I-antitrypsin levels
Nawal Kishore Agrawal, Prasad, R., Manju
Sharma and Sharma, B.B., S.N. Medical College and Hospital, Agra,
Uttar Pradesh, Asian Medical Journal
(1982): 9, 647.
- Role
of Liv.52 in management of Indian childhood cirrhosis
Shakuntala Saxena (Mrs.), Ashok Kumar
Garg and Ashok Jain, Department of Paediatrics, S.M.S. Medical
College and Hospital, Jaipur, Rajasthan, Current Medical Practice.
(1980): (24), 7, 269.
- Role
of Liv.52 in hepatitis and cirrhosis of the liver
Mallik K.K. and Pal, M.B., Department
of Medicine, Institute of Postgraduate Medical Education and Research,
Calcutta, West Bengal, Current Medical Practice (1979): 23, 5.
- Liv.52
in the treatment of cirrhosis of liver – Certain observations
Singh, K.K., Department of Medicine, Singh,
Y.K., Dubey, K.M., Department of Biochemistry, Sharma, V., Department
of Medicine, and Mishra, B.N., Darbhanga Medical College, Laheriasarai,
Bihar, The Antiseptic (1979): (76), 7, 393.
- A
study of therapeutic actions of Liv.52 on various stages, severity,
and activity of portal cirrhosis and infective hepatitis
Sinha, P.K., B.R.D. Medical College, Gorakhpur,
Uttar Pradesh, Ashok Kumar and Patney, N.L., Post-graduate Department
of Medicine, S.N. Medical College, Uttar Pradesh, Probe (1979):
(XVIII), 3, 157.
- Study
of Liv.52 therapy in cases of Indian childhood cirrhosis and other
liver disorders
Mehar Singh and Agrawal, V.K., S.N. Children’s
Hospital, M.L.N. Medical College, Allahabad, Uttar Pradesh, Probe
(1978): (XVII), 2, 169.
- Management
of steatorrhoea of cirrhosis of the liver by an indigenous drug
– Liv.52
Patney, N.L., Jasuja, R.K. and Ashok Kumar,
Postgraduate Department of Medicine, S.N. Medical College, Agra,
Uttar Pradesh, Probe (1976): (XV), 3, 164.
- Liv.52
– A clinico-biochemical trial in hepatic cirrhosis
Mehrotra, M.P. and Tandan, S., S.N. Medical
College, Agra, Uttar Pradesh, Current Medical Practice (1973):
(17), 4, 185.
- Hepatic
cirrhosis in the tropics
Mukerjee, A.B., Calcutta National Medical
College and Hospital, Calcutta, West Bengal, Dasgupta, M., Resident
University of Tennessee College of Medicine, USA, and Sarkar,
S.K., N R Sarkar Medical College, Calcutta, West Bengal, Probe
(1973): (XII), 2, 91.
- Liv.52
– A new therapeutic agent in the management of steatorrhoea
of cirrhosis of the liver
Patney, N.L., Jasuja, R.K. and Ashok Kumar,
Postgraduate Department of Medicine, S.N. Medical College, Agra,
Uttar Pradesh, Journal of Research in Indian Medicine (1973):
3, 28.
- Long-term
studies on the therapy of hepatic damage and cirrhosis of liver
Lala Surajnandan Prasad, Patna Medical
College and Prince of Wales Hospital, Patna, Bihar Sinha, K.N.,
Prince of Wales Hospital, Patna, Bihar, Devendra Tripathy and
Prasad, K., Research Scholar, Patna, Bihar, Current Medical Practice
(1971): (15), 12, 1071.
- Cirrhosis
of liver – Results of treatment with an indigenous drug:
Liv.52
Mukerjee, A.B. and Dasgupta, M., Department
of Medicine, Ramakrishna Mission Seva Pratishthan, Calcutta, West
Bengal, Journal of Indian Medical Profession (1971): 17, 7853.
- B.S.P.
test in the evaluation of therapy in hepatic cirrhosis by an indigenous
drug – Liv.52
Dasgupta, M., Ramakrishna Mission Seva
Pratishthan, Calcutta, West Bengal,and Mukerjee, A.B., Calcutta
National Medical College and Hospitals, Calcutta, West Bengal,
The Indian Practitioner (1970): 12, 739.
- Cirrhosis
of liver
Shantilal C. Sheth and Tibrewala, N.S.,
Bharat Medical Journal (1970): (2), 2, 130.
- Liv.52
– Infantile cirrhosis
Paulose, P.M., The Indian Practitioner
(1963): 6, 516.
- Clinical
and histopathological evaluation of Liv.52 in cirrhosis in liver
Vyas, K.J., General Hospital, Junagadh,
Gujarat, Probe (1963): 2, 66.
- Treatment
of hepatopathy in children with a combination of capparis spinosa
and other Indian indigenous drugs
Vyas, K.J., Children Ward, General Hospital,
Junagadh, Gujarat, Medical Digest (1961): (29), 3, 105.
- Therapy
of cirrhosis of liver and liver damage with indigenous drugs –
Experimental and clinical studies
Shantilal C. Sheth, Basil J. Northover,
Tibrewala, N.S., Warerkar, U.R. and Karande, V.S. B.Y.L. Nair
Hosptial and Topiwala National Medical College and the Christian
Medical College and Hospital, Vellore, Tamil Nadu, Indian Journal
of Paediatrics (1960): 27, 204.
- Liv.52
therapy in cirrhosis of liver in children
Vyas, K.J., Indian Journal of Child Health
(1960): 5, 244.
- Treatment
of infantile cirrhosis with an indigenous preparation
Vyas, K.J., Children Hospital, Sir T.
Hospital, Bhavnagar, Gujarat, The Indian Practitioner (1958):
(XI), 1, 107.
- Some
clinical observations on the use of Liv.52 (An indigenous drug)
in cases of cirrhosis of liver in children
Mathur, P.S., Hamidia Hospital, Bhopal,
Madhya Pradesh, Current Medical Practice (1957): 5, 107.
|
|
| |
|
| In the prevention
and treatment of protein energy malnutrition |
|
- Malnourished
children and Liv.52
Renu Patel and Pereira, L., Department
of Paediatrics, J.J. Group of Hospitals, Bombay, Maharashtra,
The Indian Practitioner (1993): (XLVI), 7, 523.
- A
study of the effect of Liv.52 syrup on malnourished children in
rural area
Syed Fiaz Peeran, District Health Officer,
Madurai District, Manivasagam, M. and Unnamalai, R., Primary Health
Centre, Ammayanaickanur, Madurai District, Tamil Nadu, Capsule
(1982): 4, 74.
- Effect
of Liv.52 therapy in malnourished children
Shakuntala Saxena, (Mrs.), Ashok Kumar
Garg and Ashok Jain, Department of Paediatrics, S.M.S. Medical
College and Hospital, Jaipur, Rajasthan, Current Medical Practice
(1980): 6, 229.
- Role
of Liv.52 in children with malnutrition
Phadke, M.A. (Mrs.), Arkadi, D.P., Sainani,
G.S., Upgraded Department of Medicine, and Phadke, M.V., Department
of Medicine and Department of Paediatrics, B.J. Medical College
and Sassoon General Hospitals, Pune, Maharashtra, Probe (1978):
(XVII), 2, 160.
- A
study of the growth-promoting effect of Liv.52 in malnutrition
(A clinical trial)
Shrivastava, D.K., Singwekar, A.G., Thawaani,
Y.P. and Tiwari, A.K., Department of Child Health, G.R. Medical
College and K.R. Hospital, Gwalior, Madhya Pradesh, Probe (1978):
(XVII), 4, 305.
- Role
of Liv.52 in the treatment of malabsorption syndrome
Tripathi, S.N., Misra, A.K., Upadhyaya,
K.N., Dixit, O.P. and Srivastava, S.K., Department of Kayachikitsa,
Institute of Medical Sciences, Banaras Hindu University, Varanasi,
Uttar Pradesh, Journal of Research in Indian Medicine, Yoga and
Homeopathy (1977): 1, 49.
- Management
of protein-calorie malnutrition with Liv.52 as an adjuvant
Bhandari, B., R.N.T. Medical College and
General Hospital, Udaipur, Rajasthan, Probe (1976): (XV), 4, 245.
- Liv.52
in sub-optimal growth
Desai, A.B. and Shah, A.A., Department
of Paediatrics, B.J. Medical College, Ahmedabad, Gujarat, Probe
(1976): (XV), 4, 247.
- A
clinical study of the effect of Liv.52 on the growth pattern of
normal and malnourished children in a rural area – 310 cases
Reddy, Y.R., Sulochana, K.S. and Mathur,
Y.C., Niloufer Hospital, Hyderabad, Andhra Pradesh, Paediatric
Clinics of India (1975): 3, 157.
- Liv.52
therapy in cases of malnutrition, infective hepatitis, infantile
cirrhosis and anorexia (A clinico-pathological study)
Dayal, R.S., Kalra, K., Mital, V.P. and
Rajiv Sharan, S.N. Medical College, Agra, Uttar Pradesh, The Antiseptic
(1974): (71), 2, 89.
- Liv.52
in malnutrition and sub-optimal growth
Desai, A.B. (Mrs.), B.J. Medical College
and Civil Hospital, Ahmedabad, Gujarat, Probe (1974): (XIII),
4, 167.
- Clinico-biochemical
trials with an indigenous drug: Liv.52 – In malnutrition
Mathur, P.S., Chandra, I. and Khan, M.A.,
Department of Paediatrics, M.G.M. Medical College, Indore, Madhya
Pradesh, Probe (1974): (XIII), 3, 136.
- Clinical
evaluation of Liv.52 therapy in malnutrition during infancy and
childhood
Dave, D.S., Rajput, V.J., Gupta, M.R.,
Jain, V.K. and Lavangikar, U. (Miss.), Department of Paediatrics,
G.R. Medical College, Gwalior, Madhya Pradesh, Probe (1973): (XIII),
1, 1.
- Clinical
trial of Liv.52 drops
Mangalam, S. and Sunderavalli, N., Government
Royapettah Hospital, Bombay, Maharashtra, Mediscope (1973): (XVI),
1, 23.
- The
effect of Liv.52 on the pattern of weight-gain in children with
marasmus and other degrees of malnutrition as compared with that
of non-virilizing androgens
Tirumala Rao, P., Aziz Mohd. Khan and
Anjaiah, K., Department of Paediatrics, Gandhi Hospital, Secunderabad,
Andhra Pradesh, Probe (1973): (XII), 2, 78.
- Malnutrition
– Hepatic function and Liv.52 therapy
Khetarpal, S.K., Leela Ramkumar and Ram
Lubhaya, Department of Paediatrics, Medical College, Patiala,
Punjab, Current Medical Practice (1972): (16), 11, 481.
- Comparative
trial of Liv.52 and orabolin in marasmus
Tirumala Rao, P., Aziz Mohd. Khan and
Anjaiah, K., Secunderabad, Andhra Pradesh, Indian Journal of Paediatrics
(1972): (39), 227.
- Liv.52
therapy in hypoproteinaemia
Vasant R. Pai, Borgave, M.A., Sule, C.R.,
Kale, S.S. and Sudam Kale, Department of Medicine, B.J. Medical
College, Sassoon Hospitals, Poona, Maharashtra, Journal of Indian
Medical Profession (1972): 6, 8447.
- A
clinico-pathological study of hepatomegaly with special reference
to Liv.52 therapy
Dayal, R.S., Kalra, K., Rajvanshi, V.S.
and Baheti, P.C., S.N. Medical College, Agra, Uttar Pradesh, Journal
of Indian Medical Profession (1970): (17), 9, 7768.
- Effect
of Liv.52 on growing rats under the influence of corticosteroids
Kulkarni, S.D. and Joglekar, G.V., Department
of Pharmacology, B.J. Medical College, Poona, Maharashtra, The
Indian Practitioner (1970): 5, 299.
|
|
| |
|
| In the prevention
and treatment of loss of appetite |
|
- Clinical Evaluation and safety of Liv.52 Drops in the management of loss of
appetite in children: A subset analysis
Subhasish S. Bhattacharya,Department of Pediatrics, Medical College, Kolkata, India Pralhad S. Patki, M.D., Head - Medical Services and Clinical Trials, S.K. Mitra, M.D., Executive Director,R&D Center, The Himalaya Drug Company, Bangalore-562 123, India. The Antiseptic 2008; 105(3): 139-141
- Evaluation of efficacy and safety of Liv.52 tablets & Liv.52 drops in anorexia in children.
Subhasish Bhattacharya, Department of Pediatrics, Medical College, Kolkatta Kolhapure, S.A., R&D Center, The Himalaya Drug Company, Bangalore, India. Capsule (2004): (XLIV), 1, 1.
- Effect
of Liv.52 on fenfluramine-induced anorexia
Gokhale, M.S., R&D Centre, The Himalaya
Drug Co., Bombay, Maharashtra, Probe (1990): (XXIX), 3, 186.
- Liv.52
in anorexia of varying aetiology
Dharmalingam, A. and Chandrasekaran, K.,
Bhavani, Periyar District, Tamilnadu, Probe (1985): (XXIV), 4,
233.
- Liv.52
in post-cholecystectomy dyspepsia
Misgar, M.S., Karihaloo, Mir Nazir Ahmed,
Sethi, S.K. and Mohd. Yousuf Wani, Department of Surgery, Government
Medical College, Srinagar, Jammu and Kashmir, Probe (1984): (XXIII),
3, 150.
- Infant
feeding problems and the role of Liv.52
Dharam B. Sharma and Lahori, U.C., Children’s
Hospital, Medical College, Jammu, Jammu and Kashmir, Probe (1980):
4, 275.
- Biological
rhythms and medicine
Kulkarni, R.D., Grant Medical College,
Bombay, Maharashtra, Current Medical Practice (1980): (24), 8,
305.
- The
anabolic activity of Liv.52
Aslam, M. and Aslam, S., Department of
Obstetrician and Gynaecology, Jawaharlal Nehru Medical College,
Aligarh Muslim University, Aligarh, Uttar Pradesh, Probe (1979):
(XVIII), 2, 74.
- Effect
of Liv.52 on anorexia of varied aetiology
Anil Mohan and Reddy S.V.R., Institute
of Paediatrics and Child Health, Andhra Medical College, Visakhapatnam,
Andhra Pradesh, Probe (1975): (XIV), 2, 136.
- Observation
on the anabolic effects of Liv.52 in burns
Sinha, R.N., Singh, Y. and Madan, P.,
Department of Plastic Surgery, Patna Medical College Hospitals,
Patna, Bihar, Indian Journal of Plastic Surgery (1972): (5), 1,
26.
- Effect
of Liv.52 in anorexia of hookworm disease (A preliminary study)
Dutta, J.K., Balak Ram Hospital, Delhi,
Probe (1971): (XI), 1, 26.
- Liv.52
in anorexia in paediatric practice
Saxena, S., S.M.S. Medical College, Jaipur,
Rajasthan, Current Medical Practice (1971): 15, 580.
- Liv.52
in anorexia in children
Sesha Chari, K.R., Kakatiya Medical College,
Warangal, Andhra Pradesh, Bharat Medical Journal (1971): 2, 181.
- Study
on Liv.52 – An indigenous anabolic compound
Sunita D. Kulkarni, Kulkarni, D.S., Vasantgadkar,
P.S. and Joglekar, G.V., Department of Pharmacology, Physiology
and Anatomy, B.J. Medical College, Poona, Maharashtra, The Indian
Practitioner (1971): 2, 145.
- Therapy
of anorexia with Liv.52
Indira Bai, K., Mallikarjuna Rao, V.P.R.
and Subba Rao, K.V., S.V. Medical College, and S.V.R.R. Hospital,
Tirupati, Andhra Pradesh, The Antiseptic (1970): 67, 615.
- Treatment
of anorexia by Liv.52
Mukherji, J.P., Moti Lal Nehru Hospital,
Jabalpur Cantonment, Madhya Pradesh, Probe (1969): (IX), 1, 25.
- Mechanism
of anorexia and effect of Liv.52 on food intake
Athavale, V.B., Lokmanya Tilak Municipal
General Hospital, Sion, Bombay, Maharashtra, Probe (1966): 6,
12.
- Anabolic
effect of Liv.52
Damle, V.B. and Deshpande, K.J., Bombay,
Maharashtra, Port Trust, Bombay, Maharashtra, The Indian Practitioner
(1966): 19, 357.
- Therapy
of anorexia with Liv.52
Shantilal C. Sheth, Tibrewala, N.S., Warerkar,
U.R. and Karande, V.S., B.Y.L. Nair Hospital and Topiwala National
Medical College, Bombay, Maharashtra, Probe (1963): 4, 137.
|
|
| |
|
| In the prevention
and treatment of radiation and chemotherapy-induced liver damage |
|
- Herbomineral
preparations as adjuvants to chemotherapy in cancer breast
Durgesh Kumar Acharya, M.K.C.G. Medical
College and Hospital, Berhampur, Ganjam, Orissa, The Antiseptic
(1994): (91), 2, 67.
- Role
of Liv.52 in alopecia-induced by radiation and chemotherapy
Harbans Lal Kapoor, Rajeev K. Seam and
Sanjeev Sharma, Department of Radiation and Oncology, Indira Gandhi
Medical College, Shimla, Himachal Pradesh, Probe (1990): (XXIX),
3, 215.
- Rifampicin
toxicity and Liv.52
Purohit, S.D., Dilip K. Jain, Meena, R.C.,
Gupta, M.L., Gupta, P.R., Mathur, B.B., Gehlot, S.L. and Mehta,
Y.R., Department of Respiratory Diseases and Tuberculosis, S.M.S.
Medical College, Jaipur, Rajasthan, Probe (1988): (XXVII), 4,
261.
- Effectiveness
of Liv.52 against radiation sickness and dermatitis
Saini, M.R., Sunil Kumar, Department of
Zoology, University of Rajasthan, Jaipur, Rajasthan, Jagetia,
G.C., Department of Radiotherapy and Oncology, Kasturba Medical
College Hospital, Manipal, Karnataka, and Navita Saini, Department
of Paediatrics, E.S.I. Hospital, Jaipur, Rajasthan The Indian
Practitioner (1984): December, 1133.
- Liver
protection by Liv.52 in lipid peroxidation
Soman, R.N., Bhatia General Hospital,
Tardeo, Bombay, Maharashtra, Probe (1984): (XXIII), 2, 110.
- Clinical
evaluation of Liv.52 as an adjuvant in cancer cases getting large
field irradiation with or without chemotherapy
Krishnan Nair, M. and Chandrasekharan
Nair, T., Department of Radiology and Cancer Institute, Medical
College Hospital, Trivandrum, Kerala, Probe (1981): (XX), 4, 288.
- A
case of radiation and drug-induced alopecia and premature greying
cured with Liv.52
Kamlakar Tripathi, Department of Medicine,
Institute of Medical Sciences, Banaras Hindu University, Varanasi,
Uttar Pradesh, Capsule (1979): 6, 122.
- Report
on the combination of a liver-stimulating preparation, Liv.52
with endoxan in the treatment of cancer
Vaidya, M.D., Katra Hospital, Mandla,
Madhya Pradesh, Probe (1978): (XVII), 2, 159.
- Changes
in serum transaminases due to hepatotoxicity and the role of an
indigenous hepatotonic Liv.52
Subbarao, V.V., University of Tripoli,
Tripoli, Libya, and Gupta, M.L., Upgraded Department of Physiology,
S.M.S. Medical College, Jaipur, Rajasthan, Yugoslavia
Physiologica Pharmacologica Acta (1976): 12.
- Clinical
trial with Liv.52 in cases of malignant diseases treated at the
barnard Institute of radiology
Gajaraj, A. and Munuswamy, G., Barnard
Institute of Radiology, Government General Hospital, Madras, Tamil
Nadu, The Antiseptic (1972): (69), 8, 570.
|
|
| |
|
| As an adjuvant with
hepatotoxic drugs |
|
- Effect of
hepatoprotective agent Liv.52 on nutrition parameters in hemodialysis patients
Gordana Perunicic-Pekovic, Ljiljana Komadina, Steva Pljesa,
Zorica Rasic-Milutinovic, Rodoljub Markovic, Department of Nephrology, University Hospital,
Zemun-Belgrade and Natasa Milic, Institute of Statistics, Belgrade Medical School, Zemun-Belgrade,
Medicine Update - Anniversary Issue, 2003, pp. 52-56.
- Effect
of phytotherapy on prevention and elimination of hepatotoxic reactions
in patients with pulmonary tuberculosis and carriers of hepatitis
B virus markers
Galitsky, L.A., Barnaulov, O.D., Zaretskii,
B.V., Malkov, M.I., Konenkov, S.I., Gol’m, N.P., Tomakov,
V.S., Ogarkov, P.I. and Batskov, S.S. Military Academy of Medicine,
Human Brain Institute of the Russian Academy of Sciences, Saint-Petersburg,
Russia, Problems of Tuberculosis,
(1997): 4, 35.
- Hepatoprotective
role of Liv.52 against hepatitis-induced by antitubercular drugs
Ashish Khare, Department of Medicine,
Institute of Medical Sciences, Banaras Hindu University, Varanasi,
Uttar Pradesh, Probe (1992): (XXXI), 3, 260.
- Efficacy
of Liv.52 and Geriforte as adjuvant in various carcinomas
Durgesh Kumar Acharya, Regional Centre
for Cancer Research and Treatment, Cuttack, Orissa, Probe (1986):
(XXV), 3, 249.
- Role
of Liv.52 in cyclophosphamide-induced alopecia
Harbans Lal Kapoor, Seam, R.K. and Sanjiv
Sharma, Department of Radiation Therapy and Oncology, Indira Gandhi
Medical College, Simla, Himachal Pradesh, Probe (1986): (XXV),
4, 344.
- Hepatoprotective
role of indigenous drug Liv.52 in lepromatous leprosy
Pranesh Nigam and Mukhija, R.D., B.R.D.
Medical College, Gorakhpur, Dayal, S.G., Government Medical College,
Jammu-Tawi, Goyal, B.M. and Joshi, L.D., M.L.B. Medical College,
Jhansi, Madhya Pradesh, Hansenlogia
Internationalis, Brazil (1982): 7, 1, 36.
- Experience
with Liv.52 as an adjuvant to anti-tubercular treatment
Vinod Kumar Gupta, The Sincere Dispensary
and Nursing Home, Rori Bazar, Sirsa, Haryana, Capsule (1980):
6, 122.
- Effect
of Liv.52 on hepatic enzymes
Alok Saxena and Garg, N.K., Division of
Biochemistry, Central Drug Research Institute, Lucknow, Uttar
Pradesh, Indian Journal of Experimental Biology (1979): 7, 662.
- The
effect of Liv.52 on liver functions of tubercular patients receiving
second line anti-tubercular drugs
Brij Kishore, Hazra, D.U., Sachan, A.S.,
Agrawal, B.M., Bharadwaj, Ashok Kumar and Mehrotra, M.M.N., Postgraduate
Department of Medicine, S.N. Medical College, Agra, Uttar Pradesh,
Probe (1978): (XVII), 2, 125.
- Some
observations with Liv.52 therapy in cases of malignancy
Harish Kulkarni, R.S.T. Cancer Centre,
Nagpur, Maharashtra, Probe (1978): (XVII), 3, 233.
- Effect
of an indigenous (herbal) drug Liv.52 on the hepatic damage caused
by oral contraceptives – A biochemical (enzymatic) approach
Khuteta, K.P., Upgraded Department of
Physiology and Biochemistry, S.M.S. Medical College, Jaipur, Rajasthan,
Probe (1978): (XVII), 2, 115.
- Leprous
hepatitis: Clinico-pathological study and therapeutic efficacy
of Liv.52
Pranesh Nigam, Dayal, S.G., Goyal, B.M.,
Nimkhedakar, K., Joshi, L.D. and Samuel K.C., M.L.B. Medical College,
Jhansi, Uttar Pradesh, Leprosy in India (1978): (50), 2, 185.
- Anorexia
in osteoarticular tuberculosis
Dabral, P.K., Srivastava, M.K. and Madhu
Dabral (Mrs.), M.L.B. Medical College, Jhansi, Madhya Pradesh,
Probe (1976): (XV), 3, 199.
- Role
of Liv.52 in hepatomegaly associated with childhood tuberculosis
(A clinico-histopathological study)
Kumar, P. and Shishupal Ram, Department
of Paediatrics, Patna Medical College Hospital, Patna, Bihar,
The Indian Practitioner (1975): 10, 535.
- Place
of Liv.52 as an adjuvant to chemotherapy of malignant diseases
Munuswamy, G. and Gajraj, A., Barnard
Institute of Radiology and Cancer, Government General Hospital
and Madras Medical College, Madras, Tamil Nadu, Probe (1975):
(XV), 1, 1.
- Liv.52
as adjuvant therapy with hepatotoxic and cytotoxic drugs
Vaidya, M.D., Katra Hospital, Mandla,
Madhya Pradesh, Probe (1974): (XIII), 2, 73.
- Liv.52
improves thioacetazone tolerance
Major Jayaram, C.N., T.B. Sanatorium,
Austinpatti, Madurai, Tamil Nadu, Probe (1969): (VIII), 4, 160.
|
|
| |
|
| Prevention of Hepatotoxicity in Patients Receiving Antitubercular Drugs |
|
- Liv.52 in the Prevention of Hepatotoxicity in Patients Receiving Antitubercular Drugs: A Meta-analysis
SV Dange Professor, Dept. of Pharmacology DY Patil Medical College, Hospital and Research Centre, Pune Indian Journal of Clinical Practice, Vol. 21, No. 2, July 2010
|
|
| |
|
| Miscellaneous |
|
- Effect
of Liv.52 in digestive disorders among children
Khrushcheva, N.A. and Safronova, L.E., State Medical Academy
based in Ural, Regional Children's Clinical Hospital, Ekaterinburg, Russia,
Capsule (2002): (XLI), 4, January / March.
- Use
of hepatoprotective agents in hepatomegaly syndrome in children:
An experience with Liv.52 Syrup
Otilia Marginean, MD, PhD, Ioana Micle,
MD, PhD, Maria Lesovici, MD, PhD, Pediatric Hospital "Louis
Turcanu", Timisoara, Romania, Raluca Balean, MD, Budiu Ioana,
MD, County Hospital Nr. 1, Timisoara, Romania, and Edited by:
Kala Suhas Kulkarni, MD, MCPS Medical Advisor, R&D Center,
The Himalaya Drug Company, Bangalore, Karnataka, India, Medicine
Update (2002): (10), 8, 57.
- Physiological Icterus of the newborn and the role of Liv.52
Goel, S.P., Lecturer, Department of Pediatrics,
Garg, B.K., Professor and Head of the Department of Pediatrics
Sharma, D.K., Professor in the Department of Pediatrics, Upadhyay,
V.K., Lecturer in the Department of Pediatrics, L.L.R.M. Medical
College, Meerut, India, Probe (1994): (XXXIV), 1, 45.
- Role
of Liv.52 and Geriforte as general metabolic tonics in drug addicts
Jain, N.C., Government Rajindera Medical
College and Hospital, Patiala, Singal, R.P., Dayanand Hospital,
Ludhiana, Punjab, and Shahi, S.R., S.S.M.D. Ayurvedic College
and Hospital, Moga, Punjab, Probe (1992): (XXXII), 1, 32.
- The
treatment of non-suppurative hepatic amoebiasis with Liv.52 as
an adjuvant to antiamoebic drugs
Bose, S.L. and Rout, A.K., Department
of Medicine, S.C.B. Medical College, Cuttack, Orissa, Indian Medical
Journal (1983): 1, 3.
- Role
of Liv.52 in the treatment of pityriasis alba
Chakraborty, A.K., G.T. Road, Kalitala,
Serampore, West Bengal, Capsule (1983): 1, 9.
- Liv.52
in burns cases
Malla, C.N. and Surinder Singh, Medical
College and H.M.H.S. Hospital, Srinagar, Jammu and Kashmir, Probe
(1982): (XXII), 1, 24.
- Clinical
trial of Liv.52 in burns
Parangusa Das, R.A., Vijayalakshmi, B.
and Subhashini, M.,Victoria Hospital, Bangalore, Karnataka, Probe
(1982): (XXI), 3, 192.
- Role
of Liv.52 in psychiatric illness
Rustom N. Burjorjee, Calcutta Medical
Centre, London Street, Calcutta, West Bengal, Capsule (1982):
5, 98.
- A
case study on Liv.52 an adjuvant in diabetes mellitus
Sinha, A.K., P.T.P.S. Hospital, Patralu,
District, Hazaribagh, Bihar, Capsule (1982): 8, 178.
- Effect
of Liv.52 on liver lipids
Alok Saxena, Sharma, S.K. and Garg, N.K.,
Department of Biochemistry, Central Drug Research Institute, Lucknow,
Uttar Pradesh, Indian Journal of Experimental Biology (1980):
11, 1330.
- Evaluation
of Liv.52 in the treatment of jaundice with pregnancy
Arun Kumar Mitra and Abhik De, Calcutta
Medical College, West Bengal, Probe (1978): (XVII), 2, 143.
- Liv.52
in herpes-progenitalis
Iswar Tanwani, Howrah Road, Deolali Cantonment,
Nasik District, Maharashtra, Journal of National Integrated Medical
Association (1976): (18), 3, 98.
- Effect
of Liv.52 on serum lipids in normal and patients suffering from
ischaemic heart disease
Rao, C.R. and Subba Rao, A., Bowring and
Lady Curzon Hospital, Postgraduate and Research Institute, Bangalore,
Karnataka, Probe (1975): (XIV), 3, 177.
- Radioactive
Rose Bengal test of liver function – A preliminary report
of Liv.52 trial
Rajagopal, K.R., Radio-Isotope Department,
Barnard Institute of Radiology, Government General Hospital, Madras,
Tamil Nadu, Probe (1974): (XIV), 1, 50.
- A
clinical study of the therapeutic efficacy of Liv.52 as an adjuvant
in the treatment of hepatic amoebiasis
Sethi, J.P. and Suresh Meratwal, Department
of Medicine, S.M.S. Medical College and Attached Hospital, Jaipur,
Rajasthan, Probe (1973): (XII), 3, 129.
- Gastrointestinal
allergy treated with Liv.52 – A case report
Tripathi, A.R., Department of Forensic
Medicine, Institute of Medical Services, Banaras Hindu University,
Varanasi, Uttar Pradesh, Capsule (1973): June/July, 30.
- Liv.52
in dermatology
Behl, P.N., Skin Institute, Delhi, Probe
(1972): (XI), 2, 100.
- Therapy
of toxaemias of pregnancy
Narone, J.N., and Raj Narone (Mrs.), Department
of Gynaecology and Obstetrics, Patna Medical College, Patna, Bihar,
Probe (1972): (XI), 2, 120.
- Some
studies on physiological jaundice of the new-born
Srivastava, J.R., Bhalla, J.N. and Arora,
A., G.S.V.M. Medical College, Kanpur, Uttar Pradesh, Probe (1972):
(XII), 1, 4.
- Liv.52
in vitiligo
Punshi, S.K. Consultant Dermatologist
and Abroal, S.K., Amravati, M.S., Probe (1970): (X), 1, 12.
- Studies
with Liv.52
Lala Surajnandan Prasad, Department of
Paediatrics, Patna University, Patna, Bihar and Devendra Tripathy,
Hospital for Children, Patna Medical College Hospital, Patna,
Bihar, Probe (1969): (IX), 1, 1.
- Metabolic
effect of an indigenous compound on sportsmen
Mathur, D.N., The National Institute of
Sports, Patiala, Punjab, Probe (1969): (VIII), 4, 144.
- Liv.52
in general practice
Shah, N.B., Malegaon City, Nasik, Maharashtra,
Probe (1969): (VIII), 3, 101.
- A
clinical study – Physiological jaundice in neonates
Chafekar, V.D., Annapoornabai Maternity
and Nursing Home, Gadag, Karnataka, Probe (1968): (VII), 3, 85.
- Observations
on Liv.52
Patrao, S., B.Y.L. Nair Hospital and T.N.
Medical College, Bombay, Maharashtra, Journal of Indian Medical
Profession (1957): 8, 1878.
- Ascitis
due to liver deficiency treated with an indigenous drug
Sule, C.R., Sathe, P.M., Koshy, M.C. and
Desphande, M.S., The Indian Practitioner (1956): (IX), 4, 357.
|
|
|
|
|
|
| |
|
|
|
|
